Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

IKTIKT
5 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in INHIBIKASE THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 275,041 shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $558,333 as of 2026-Q2. The position was increased (+16.8% shares). IKT represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$558,333

Current Shares

275,041

Total Value Change

+$261,352

Total Shares Change

+122,743

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
275,041
+16.8%
$558,3330.0%$2.03
28
2026-Q1
Increased
235,414
+54.6%
$395,4960.0%$1.91
34
2025-Q4
Unchanged
152,298
0.0%
$312,2110.0%$1.97
0
2025-Q3
Unchanged
152,298
0.0%
$246,7230.0%$1.53
0
2025-Q2
New
152,298
-
$296,9810.0%$1.62
32

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used